Alder BioPharma (ALDR) Misses Q2 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. GOOGL
3. MSFT
4. FTNT
5. EBAY
6. TENB
7. CMG
8. KLAC
9. BIIB
10. ETSY

Go back to Alder BioPharma (ALDR) Misses Q2 EPS by 6c

Leerink Partners Raises Price Target on Alder BioPharma (ALDR) to $62 Following 2Q15

August 6, 2015 10:03 AM EDT

Leerink Partners reiterated an Outperform rating on Alder Biopharm (NASDAQ: ALDR), and raised the price target to $62.00 (from $40.00), following 2Q15 results. ALDR reported 2Q15 EPS of $(0.46) that was below consensus estimates of $(0.40).

Analyst Joseph Schwartz commented, "On Wednesday (8/5) after the close, ALDR... More